More or Less: Antibiotics and the Problem of the Broken Market

If we don’t get new antibiotics, as they become more resistant it is likely that people will die. It’s a huge business but there’s a problem - pharmaceutical companies are reluctant to invest time and money to develop new antibiotics. But why not?

(Image: Computer artwork of bacteria - credit: Science Photo Library)